NCT01862887View on ClinicalTrials.gov

A Study to Investigate the Effect of PH-797804 on QTc Interval

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions

Healthy

Interventions

DRUG

PH-797804

Tablet, 24 mg, single dose

DRUG

Moxifloxacin

Tablet, 400 mg, single dose

DRUG

Placebo

Tablet, PH-797804 matched placebo, single dose

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT01862887 - A Study to Investigate the Effect of PH-797804 on QTc Interval | Biotech Hunter | Biotech Hunter